IP Library Granted Patent US 7,091,382
Granted Patent B2
US 7,091,382 · App. 10/841,403 · Granted Aug 15, 2006

Synthesis of N-methyl-N-phenylaminoacrolein

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,091,382
App. No.
10/841,403
Granted
Aug 15, 2006
Kind
B2
Abstract

A process is disclosed for manufacturing N-methyl-N-phenylaminoacrolein of formula (I) which comprises reacting N-methylformanilide and an alkyl vinyl ether of formula (III) wherein R is a C 3 –C 4 alkyl, said process being characterized in that the reaction between N-methylformanilide and said alkyl vinyl ether of formula (III) is carried out in the presence of phosgene, diphosgene or triphosgene in a solvent selected from dioxane, acetonitrile and/or chlorobenzene.

Claims (21)

1. A process for manufacturing N-methyl-N-phenylaminoacrolein of formula (I)

comprising the step of reacting N-methylformanilide and an alkyl vinyl ether of formula (III)

wherein R is a C 3 –C 4 alkyl, wherein the reaction between said N-methylformanilide and said alkyl vinyl ether of formula (III) is carried out in the presence of triphosgene in a solvent selected from the group consisting of dioxane, acetonitrile chlorobenzene and mixtures thereof.

2. A process according to claim 1 , wherein said solvent is chlorobenzene.

3. A process according to claim 1 , wherein R is selected from the group consisting of ethyl, n-propyl, n-butyl, isobutyl and mixtures thereof.

4. A process according to claim 1 , wherein the reaction is carried out at a temperature of 0 to 50° C.

5. A process according to claim 1 , wherein the reaction is carried out at a temperature of 15 to 25° C.

6. A process according to claim 1 , wherein the reacting step further comprises adding at least one of 1.0 to 1.3 equivalents of phosgene, 0.5 to 0.65 equivalents of diphosgene or 0.34 to 0.43 equivalents of triphosgene to an equimolar solution of N-methylformanilide and said alkyl vinyl ether of formula (III).

7. A process for manufacturing N-methyl-N-phenylaminoacrolein of formula (I)

comprising the steps of reacting N-methylformanilide and an alkyl vinyl ether of formula (III)

wherein R is a C 3 –C 4 alkyl, wherein the reaction between said N-methylformanilide and said alkyl vinyl ether of formula (III) is carried out in the presence of triphosgene in a solvent selected from the group consisting of dioxane, acetonitrile chlorobenzene and mixtures thereof

and an aqueous solution of alkaline hydroxide or carbonate to form an aqueous phase and at least one organic phase,

separating the aqueous phase from the at least one organic phase, and evaporating to residue of the at least one organic phase.

8. A process according to claim 1 , further comprising

evaporating the solvent to form a residue and taking up the residue with an aqueous solution of alkaline hydroxide or carbonate and a solvent selected from the group consisting of tert-butyl methyl ether, chlorobenzene, toluene and mixtures thereof.

9. A process according to claim 7 , further comprising the step of extracting the N-methyl-N-phenylaminoacrolein (I) from the aqueous phase with an ether.

10. A process according to claim 9 , wherein said ether is tert-butyl methyl ether.

11. A process according to claim 9 , further comprising the step of recrystallizing the N-methyl-N-phenylaminoacrolein (I) by adding at least one of tert-butyl methyl ether, hexane, heptane, cyclohexane, methanol, ethanol, isopropanol or mixtures thereof to the N-methyl-N-phenylaminoacrolein (I) at a temperature of between −20° C. and 0° C.

12. A process according to claim 1 , wherein the reaction is carried out at a temperature of about 20° C.

13. A process according to claim 10 , wherein tert-butyl methyl ether is used.

14. A process according to claim 10 , wherein the recrystallization step occurs at a temperature of about −15° C.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2006
From: CLARIANT LIFE SCIENCE MOLECULES (ITALY) S.P.A.
To: ARCHIMICA S.R.L.
Reel/Frame 018061/0635 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2004
From: BANFI, ALDO; MANCINI, ALFREDO
To: CLARIANT LIFE SCIENCE MOLECULES (ITAILA) S.P.A.
Reel/Frame 015315/0013 →